Nate Silver — with a strong assist from @leokitty, who has compiled a spreadsheet of public Hall of Fame votes — gives those public Hall of Fame votes the old Nate Silver treatment in his latest post.
Specifically, he looks for patterns among voters who did and didn’t vote for Barry Bonds and/or Roger Clemens in an attempt to see what that means for others on the ballot. The upshot: while Bonds and Clemens represent a clear and unambiguous case of voters weighing in on the steroid era for good or for ill, the suction is taking guys like Bagwell and Piazza down with them. Which, if you’re not yet sick of my Hall of Fame posts here, you’re well aware of.
Silver notes, however, that that suction, well, sucks, because it’s based on some pretty crude and inaccurate stereotyping by the electorate. Because — based on the sorts of players who have been suspended for performance-enhancing drugs, it makes little sense to simply assume use by the big guys and assume that the little guys were clean:
Among these players are the utility infielder Neifi Perez, who hit 64 home runs in a 12-year career, the slap-hitting outfielder Jorge Piedra, and a substantial number of pitchers. The incidence of performance-enhancing drug use seems to be fairly randomly distributed between stars and benchwarmers, players at different positions and those with different skills.
Some writers seem to think they can profile steroid users, and some otherwise-deserving players seem likely to be denied a place in Cooperstown because of it.
According to Jorge Castillo of the Washington Post, Nationals infielder Danny Espinosa declined to attend the team’s annual Winterfest because of his dissatisfaction with management following their trade for outfielder Adam Eaton.
A source told Castillo that Espinosa’s unhappiness stemmed from a belief that the acquisition would jeopardize his starting role in 2017. With Eaton in center field, Trea Turner will likely return to his post at shortstop, leaving Espinosa out in the cold — or, as the case may be, on the bench. The move shouldn’t come as a big surprise to Espinosa, however, as Nationals’ GM Mike Rizzo spoke to the possibility of trading the infielder or reassigning him to a utility role back in early November.
Offensively, the 29-year-old had a down year in 2016, slashing just .209/.306/.378 with 24 home runs in 601 PA. Defensively, he still profiles among the top shortstops in the National League, with eight DRS (Defensive Runs Saved) and 8.3 Def (Defensive Runs Above Average) in his seventh year with the club.
Espinosa will reach free agency after the 2017 season.
The Red Sox might be trying to move the wrong pitcher, according to the Boston Globe’s Nick Cafardo. Cafardo revealed that while the Sox have been trying to market right-hander Clay Buchholz, more teams would be interested in trades involving southpaw Drew Pomeranz.
The club appears reluctant to deal Pomeranz, especially because his price tag comes in at a cool $4.7 million to Buchholz’s $13.5 million in 2017. Those who have already expressed interest in the veteran hurlers, including the Twins, Mariners and Royals, also seem put off by Buchholz’s salary requirements as he enters his 32nd year.
Health could be another factor preventing teams from jumping to make trade offers, as Cafardo quotes an AL executive who believes the “medicals on both Pomeranz and Buchholz probably aren’t that great.” Neither pitcher suffered any major injuries during the 2016 season, though Pomeranz missed just over a week of play due to forearm soreness.
Pomeranz outperformed his fellow starter in 2016, pitching to a 3.32 ERA and career-best 9.8 K/9 through 170 2/3 innings with the Padres and Red Sox. He got off to an exceptionally strong start in San Diego, where his ERA dropped to 2.47 through the first half of the year before the Padres dealt him to Boston for minor league right-hander Anderson Espinoza. Buchholz, on the other hand, struggled with a 4.78 ERA and saw a decline in both his BB/9 and K/9 rates as he worked out a career-low 1.69 K/BB through 139 1/3 innings with the Sox.